7 results

• Dupixent Side Effects Lawsuit Alleges Drug Caused Cutaneous T-Cell Lymphoma

  September 24, 2026

  Irvin Jackson

  A woman's Dupixent cancer lawsuit alleges that the manufacturers should have known the eczema treatment caused a rare form of T-cell lymphoma and warned doctors and patients.

• Dupixent Side Effects Caused CTCL, Tumors, Lawsuit Alleges

  September 10, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit claims using the eczema treatment led to a man's cancer returning, leaving him with life-long medical treatment needs.

• Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis

  August 20, 2026

  Irvin Jackson

  A California woman's Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug's cancer risks, but refused to inform doctors and patients.

• Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges

  August 11, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.

• CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use

  July 29, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit claims that the manufacturer intentionally failed to warn patients or the medical community about the eczema treatment's potential cancer risks.

• Genzyme Drug Contamination: Foreign Particles may be in Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen

  November 17, 2009

  AboutLawsuits

  The FDA has warned healthcare professionals that several important drugs manufactured by Genzyme Corp., which are used to treat rare...

• Thymoglobulin Recall: Anti-Rejection Drug May Not Be Stable

  September 10, 2008

  AboutLawsuits

  The U.S. Food and Drug Administration (FDA) posted information Tuesday about a Thymoglobulin recall for one lot of the anti-rejection...